BullFrog AI Continues to Expand Team with Appointment of New VP of Business Development
07 6월 2023 - 7:30PM
BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or
the "Company"), a digital technology company using machine learning
to usher in a new era of precision medicine, today announced
the appointment of Toby Sayre, MS as VP of Business Development.
Sayre brings more than 18 years of experience in
life sciences and biotechnology consulting, business development,
product development, and client engagement to BullFrog AI. He holds
master’s degrees in Cell and Molecular Biology and Biochemistry
from San Francisco State University (SFSU) and University of
California, Los Angeles (UCLA), and has a technical background in
bioinformatics, biochemistry, real-world data, natural language
processing (NLP) and AI software.
“Toby brings a wealth of experience that will be
an invaluable asset to BullFrog AI as we continue to expand our
reach into the life sciences and biotechnology industry,” said Vin
Singh, Founder and CEO of BullFrog AI. “We are excited to welcome
Toby to our executive team and look forward to the impact he will
make on our business strategy and development efforts.”
Sayre joins BullFrog AI with a proven track
record of success in various roles, including his most recent
position as VP of RWE, Value, and Life Science Partnerships at
ConcertAI. Previously, during his tenure at Doctor Evidence, LLC,
Sayre held several key positions of increasing responsibility,
including Chief Commercial Officer, and successfully launched an
AI-enabled SaaS product that generated over $2.5 million in
annualized contracts within its first quarter. As a strategic
leader, he managed the company's commercial pivot from consulting
to SaaS, maintaining client satisfaction and achieving 25%
year-over-year growth for a $20 million revenue portfolio.
"I am thrilled to join the BullFrog AI team at
such an exciting time in the company's evolution, and I look
forward to driving innovative solutions and forging strategic
partnerships that will solidify BullFrog AI's position as a market
leader," said Sayre.
"With the addition of Toby, our expanding team
now consists of 13 dedicated professionals, both full-time and
part-time employees, as well as contracted consultants, who share a
common vision of transforming the drug development landscape,"
continued Singh.
About BullFrog AI
BullFrog AI is a digital technology company
using machine learning to usher in a new era of precision medicine.
Through its collaborations with leading research institutions,
including Johns Hopkins University, BullFrog AI is at the forefront
of AI-driven drug development. Using its proprietary bfLEAP™
artificial intelligence platform, BullFrog AI aims to enable the
successful development of pharmaceuticals and biologics by
predicting which patients will respond to therapies in development.
BullFrog AI is deploying bfLEAP™ for use at several critical stages
of development with the intention of streamlining data analytics in
therapeutics development, decreasing the overall development costs
by decreasing failure rates for new therapeutics, and impacting the
lives of countless patients that may seek to receive the therapies
they need.
For more information visit BullFrogAI at
Website: www.bullfrogai.com
LinkedIn: https://www.linkedin.com/company/bullfrogai/
Safe Harbor Statement
This press release contains forward-looking
statements. We base these forward-looking statements on our
expectations and projections about future events, which we derive
from the information currently available to us. Such
forward-looking statements relate to future events or our future
performance, including: our financial performance and projections;
our growth in revenue and earnings; and our business prospects and
opportunities. You can identify forward-looking statements by those
that are not historical in nature, particularly those that use
terminology such as "may," "should," "expects," "anticipates,"
"contemplates," "estimates," "believes," "plans," "projected,"
"predicts," "potential," or "hopes" or the negative of these or
similar terms. In evaluating these forward-looking statements, you
should consider various factors, including: our ability to change
the direction of the Company; our ability to keep pace with new
technology and changing market needs; and the competitive
environment of our business. These and other factors may cause our
actual results to differ materially from any forward-looking
statement. Forward-looking statements are only predictions. The
forward-looking events discussed in this press release and other
statements made from time to time by us or our representatives, may
not occur, and actual events and results may differ materially and
are subject to risks, uncertainties, and assumptions about us. We
are not obligated to publicly update or revise any forward-looking
statement, whether as a result of uncertainties and assumptions,
the forward-looking events discussed in this press release and
other statements made from time to time by us or our
representatives might not occur.
Contact:
Dave GentryRedChip Companies,
Inc.BFRG@redchip.com800-733-2447
SOURCE: BullFrog AI Holdings,
Inc.
Bullfrog AI (NASDAQ:BFRGW)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Bullfrog AI (NASDAQ:BFRGW)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024